Skip to main content
OpenTrials

Clinical trial condition

Essential Thrombocythemia

Explore clinical trials studying Essential Thrombocythemia. Study availability and eligibility vary by location and protocol.

72 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Essential Thrombocythemia trial results

Recruiting

A Study of GLB-001 in Patients With Myeloid Malignancies

NCT06378437

Conditions
Acute Myeloid Leukemia, Blood Coagulation Disorders, Blood Platelet Disorders, +21 more
Locations
  • The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital) Hefei, Anhui, China
  • China-Japan Friendship Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • The First Hospital of Hebei Medical Universtiy Shijiazhuang, Hebei, China
View all 14 locations
View Trial Details
Active, not recruiting

Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)

NCT06456346

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Palo Verde Cancer Specialists ( Site 0052) Glendale, Arizona, United States
  • Los Angeles Cancer Network ( Site 0025) Glendale, California, United States
  • Stanford Cancer Center ( Site 0024) Palo Alto, California, United States
  • Exempla Lutheran Medical Center ( Site 0014) Golden, Colorado, United States
View all 171 locations
View Trial Details
Active, not recruiting

A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)

NCT06079879

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +7 more
Locations
  • Palo Verde Hematology/ Oncology Center, Ltd. ( Site 3496) Glendale, Arizona, United States
  • Los Angeles Cancer Network ( Site 3491) Glendale, California, United States
  • Stanford Cancer Institute ( Site 0107) Stanford, California, United States
  • The Lundquist Institute ( Site 3423) Torrance, California, United States
View all 163 locations
View Trial Details

Related conditions